157 related articles for article (PubMed ID: 10755405)
1. Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells.
Skladanowski A; Konopa J
Br J Cancer; 2000 Apr; 82(7):1300-4. PubMed ID: 10755405
[TBL] [Abstract][Full Text] [Related]
2. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the DNA-DNA cross-linking activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin.
Jesson MI; Johnston JB; Robotham E; Begleiter A
Cancer Res; 1989 Dec; 49(24 Pt 1):7031-6. PubMed ID: 2531036
[TBL] [Abstract][Full Text] [Related]
4. DNA-protein, DNA interstrand cross-links induced by camphoramine chloroacetic platinum in vitro.
Wang LG; Zeng H
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):261-5. PubMed ID: 2609999
[TBL] [Abstract][Full Text] [Related]
5. DNA cross-linking patterns induced by an antitumor-active trinuclear platinum complex and comparison with its dinuclear analogue.
Zhu J; Zhao Y; Zhu Y; Wu Z; Lin M; He W; Wang Y; Chen G; Dong L; Zhang J; Lu Y; Guo Z
Chemistry; 2009; 15(21):5245-53. PubMed ID: 19350599
[TBL] [Abstract][Full Text] [Related]
6. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linking.
Pawlak K; Pawlak JW; Konopa J
Cancer Res; 1984 Oct; 44(10):4289-96. PubMed ID: 6467190
[TBL] [Abstract][Full Text] [Related]
8. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
Souliotis VL; Dimopoulos MA; Sfikakis PP
Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
[TBL] [Abstract][Full Text] [Related]
9. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
[TBL] [Abstract][Full Text] [Related]
10. [The study of the interaction of antineoplastic drugs mitoxantrone and ametantrone with DNA using the analysis of changes in circular dichroism spectra].
Babaian IuS; Sngrian AE; Kazarian RS; Avetisian MG; Sogomonian LR; Garibian DV
Biofizika; 1998; 43(3):422-6. PubMed ID: 9702332
[TBL] [Abstract][Full Text] [Related]
11. Preferential repair incision of cross-links versus monoadducts in psoralen-damaged plasmid DNA by human cell-free extracts.
Calsou P; Sage E; Moustacchi E; Salles B
Biochemistry; 1996 Nov; 35(47):14963-9. PubMed ID: 8942662
[TBL] [Abstract][Full Text] [Related]
12. Interactions of antitumor triazoloacridinones with DNA.
Koba M; Konopa J
Acta Biochim Pol; 2007; 54(2):297-306. PubMed ID: 17446935
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the mechanism of action of busulfan with hepsulfam, a new antileukemic agent, in the L1210 cell line.
Pacheco DY; Stratton NK; Gibson NW
Cancer Res; 1989 Sep; 49(18):5108-10. PubMed ID: 2766282
[TBL] [Abstract][Full Text] [Related]
14. DNA alkylation and interstrand cross-linking by treosulfan.
Hartley JA; O'Hare CC; Baumgart J
Br J Cancer; 1999 Jan; 79(2):264-6. PubMed ID: 9888467
[TBL] [Abstract][Full Text] [Related]
15. Photosensitization of human leukemic cells by anthracenedione antitumor agents.
Hartley JA; Forrow SM; Souhami RL; Reszka K; Lown JW
Cancer Res; 1990 Mar; 50(6):1936-40. PubMed ID: 2306743
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity.
Denny WA; Wakelin LP
Anticancer Drug Des; 1990 May; 5(2):189-200. PubMed ID: 2357264
[TBL] [Abstract][Full Text] [Related]
17. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
Kasparkova J; Vojtiskova M; Natile G; Brabec V
Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
[TBL] [Abstract][Full Text] [Related]
18. Effects of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues on DNA in HT-29 human colon carcinoma cells.
Jesson MI; Johnston JB; Anhalt CD; Begleiter A
Cancer Res; 1987 Nov; 47(22):5935-8. PubMed ID: 3664494
[TBL] [Abstract][Full Text] [Related]
19. Superior cytotoxic potency of mitoxantrone in interaction with DNA: comparison with that of daunorubicin.
Fukushima T; Kawai Y; Nakayama T; Yamauchi T; Yoshida A; Urasaki Y; Imamura S; Kamiya K; Tsutani H; Ueda T; Nakamura T
Oncol Res; 1996; 8(2):95-100. PubMed ID: 8859780
[TBL] [Abstract][Full Text] [Related]
20. Electron microscopic observations of the effects of anthraquinone derivatives on plasmid DNA.
Morier-Teissier E; Bernier JL; Coulaud D; Hénichart JP; Delain E
J Biomol Struct Dyn; 1992 Feb; 9(4):653-66. PubMed ID: 1616624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
